Who owns Sagimet Biosciences Inc (SGMT)? Superinvestor holders
3 superinvestors of the 157 tracked here hold Sagimet Biosciences Inc (SGMT) in their latest 13F filing, with $16.9M between them. Zhang Lei gives it the most weight: 0.67% of the reported portfolio. In their latest reported quarter, Andrew Spokes reduced.
Key facts
- Superinvestors holding it
- 3 of 157
- Biggest holder
- Julian and Felix Baker, $7.4M
- Largest weight
- Zhang Lei, 0.67%of their portfolio
- Combined value
- $16.9M
- Bought last quarter
- 0
- Sold last quarter
- 1
From each investor's latest 13F filing: 92 investors report Q3 2026, 65 investors report Q2 2026. Latest filing in this set: Nov 16, 2026.
| # | Investor | Share of their portfolio | Value | Shares | Last quarter | Shares moved | Quarter |
|---|---|---|---|---|---|---|---|
| 1 | Zhang LeiHHLR Advisors (Hillhouse) | 0.67% | $5.6M | 724.8K | No change | 0 | Q2 2026 |
| 2 | Julian and Felix BakerBaker Bros. Advisors | 0.04% | $7.4M | 953K | No change | 0 | Q2 2026 |
| 3 | Andrew SpokesFarallon Capital Management | 0.02% | $4M | 400K | ▼ Reduced 3.6% | −14.98K | Q3 2026 |
Quarter by quarter
| Quarter | Filings in | Holders | Combined shares | Combined value | Bought | Sold |
|---|---|---|---|---|---|---|
| Q3 2026 | 92 | 1 | 400K | $4M | 0 | 1 |
| Q2 2026 | 157 | 3 | 2.09M | $16.2M | 1 | 0 |
| Q1 2026 | 157 | 2 | 1.68M | $8.8M | 0 | 0 |
| Q4 2025 | 157 | 2 | 1.68M | $9.9M | 0 | 0 |
| Q3 2025 | 157 | 2 | 1.68M | $11.5M | 0 | 0 |
| Q2 2025 | 157 | 2 | 1.68M | $12.8M | 0 | 0 |
| Q1 2025 | 156 | 2 | 1.68M | $5.5M | 0 | 0 |
| Q4 2024 | 156 | 2 | 1.68M | $7.6M | 0 | 1 |
A quarter's holder count is out of the filings in for that quarter — the newest quarter fills up over the 45 days investors have to file.
Each holder's shares
| Investor | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|---|---|---|---|
| Andrew Spokes | 400K | 415K | — | — | — | — | — | — |
| Julian and Felix Baker | · | 953K | 953K | 953K | 953K | 953K | 953K | 953K |
| Zhang Lei | · | 724.8K | 724.8K | 724.8K | 724.8K | 724.8K | 724.8K | 724.8K |
A dash: the investor filed for that quarter without this stock among their largest positions. A dot: no filing of theirs for that quarter is on file.
Questions and answers
Which superinvestors own SGMT?
In their latest 13F filings: Zhang Lei (0.67% of the portfolio, $5.6M), Julian and Felix Baker (0.04% of the portfolio, $7.4M), Andrew Spokes (0.02% of the portfolio, $4M).
Who sold SGMT last quarter?
Reduced: Andrew Spokes (3.6% fewer shares).
How current is this?
It comes from Form 13F, which large managers file within 45 days of each quarter's end; the latest filing read here was made on Nov 16, 2026. Positions may have changed since, and a 13F shows long US-listed positions only.
Learn
Cite this page
Funkfolio, “Who owns Sagimet Biosciences Inc (SGMT)? Superinvestor holders”, data as of 16 November 2026. https://funkfolio.com/stock/SGMT/superinvestors
Underlying data: SEC EDGAR, Form 13F-HR filings of the investors tracked here.
Source: SEC EDGAR, Form 13F-HR filings of the 157 investors tracked here, matched to SGMT by security number and name. Only each investor's 150 largest positions per filing are read, so a small line in a very long portfolio is not seen, and a security held without a matched ticker cannot be found. “Last quarter” compares share counts with the investor's previous filing. Share counts are restated for a split only where a tracked investor held the stock through it. Filings appear up to 45 days after a quarter ends and show long US-listed positions only; this is not advice.